Literature DB >> 15089055

Formulation and in vitro evaluation of transdermal patches of melatonin.

N Kanikkannan1, S Andega, S Burton, R J Babu, Mandip Singh.   

Abstract

The present study was undertaken to prepare and evaluate monolithic drug-inadhesive type transdermal patches of melatonin containing penetration enhancers such as fatty alcohols, fatty acids, and terpenes. The patches were prepared using Eudragit E 100 as the adhesive polymer. The release profile of melatonin from control as well as enhancer-containing patches showed an initial burst of melatonin release for up to 4 hours and then a plateau after 8 hours. The release profiles of melatonin from patches containing various enhancers were similar to the control patch. However, the addition of enhancers in the patch increased the permeation of melatonin through hairless rat skin. The flux values of patches containing octanol, nonanoic acid, and myristic acid were higher than the control patch (no enhancer), but the differences were not statistically significant (P>0.05). Decanol, myristyl alcohol, and undecanoic acid at 5% concentrations showed significantly higher flux values through hairless rat skin (enhancement ratios 1.7, 1.5, and 1.6 for decanol, myristyl alcohol, and undecanoic acid, respectively) (P<0.05). Menthol and limonene at 5% w/w showed maximum permeation of melatonin among all enhancers studied (enhancement ratios=2.1 and 2.0 for menthol and limonene, respectively) (P<0.001). In general, there was about 4-6 hours of lag time observed before a steady state flux of melatonin was achieved. Though the flux of melatonin observed in the present study is 5-10 times higher than the required delivery rate in humans, it must be noted that the present study was performed using hairless rat skin, which is generally more permeable compared to human skin. Further studies using human skin would prove the usefulness of these patches.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15089055     DOI: 10.1081/ddc-120028716

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  4 in total

1.  Nose-to-brain transport of melatonin from polymer gel suspensions: a microdialysis study in rats.

Authors:  R Jayachandra Babu; Pankaj Patrick Dayal; Kasturi Pawar; Mandip Singh
Journal:  J Drug Target       Date:  2011-03-23       Impact factor: 5.121

2.  Biphasic flux profiles of melatonin: the Yin-Yang of transdermal permeation enhancement mediated by fatty alcohol enhancers.

Authors:  Karunya K Kandimalla; R J Babu; M Singh
Journal:  J Pharm Sci       Date:  2010-01       Impact factor: 3.534

Review 3.  Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?

Authors:  Alejandro Romero; Eva Ramos; Francisco López-Muñoz; Cristóbal De Los Ríos; Javier Egea; Emilio Gil-Martín; René Pita; Juan J Torrado; Dolores R Serrano; Antonio Juberias
Journal:  Diseases       Date:  2021-04-10

4.  Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization.

Authors:  S K Madishetti; C R Palem; R Gannu; R P Thatipamula; P K Panakanti; M R Yamsani
Journal:  Daru       Date:  2010       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.